ePACT, ICB, PCN and Trust-level prescribing analysis — at a fraction of the cost of a big data vendor. 20+ years turning NHS Open Data into decisions your commercial team can act on this week.
You already have prescribing data. What you don’t always have is time, or the right specialist, to turn it into targeting, forecasting, or a business case your team can move on.
Visual Numbers builds the pipeline, the dashboard, and the interpretation — end to end — so you get answers, not raw spreadsheets.
No handoffs between an account manager and an analyst you never speak to. You work directly with the person who builds the data pipeline, designs the dashboard, and understands what the numbers mean for your product.
Deep, current working knowledge of ePACT/PCA, SCMD, ICB and Sub-ICB geography, HES linkage, and HRG cost modelling — including the 2026 ICB boundary changes. Not a generalist BI shop applying templates to healthcare data.
The same calibre of insight you’d expect from a large data vendor, delivered faster and at a fraction of the price — because you’re not paying for account layers you don’t need.
NHS Prescribing Data & Market Intelligence
Raw and enriched prescribing data across all four UK nations — ePACT, PCA, SCMD, dispensing and retail chemist data — sourced, cleaned, and structured to answer a specific commercial question, not just handed over as a spreadsheet.
Dashboards & Reporting
Interactive, drill-down dashboards from national level down to ICB, Sub-ICB, PCN, postcode or individual GP practice — built for your team to use, not just look at once.
Consultancy & Market Analysis
Targeting, territory design, competitive market mapping, cost-saving models, and budget impact / RWE-style analysis for specific therapy areas — from someone who’s also built the underlying data infrastructure, not just the slide deck.
Most engagements start with a free 20-minute call about your NHS Open Data or prescribing data questions – no obligation, no generic sales pitch. If there’s a quick answer, you’ll get it on the call.